Drug Shortage Report for STALEVO
| Report ID | 230192 |
| Drug Identification Number | 02305941 |
| Brand name | STALEVO |
| Common or Proper name | STALEVO |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | ENTACAPONE CARBIDOPA LEVODOPA |
| Strength(s) | 200MG 25MG 100MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100FCT |
| ATC code | N04BA |
| ATC description | DOPAMINERGIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-06-12 |
| Estimated end date | 2024-07-12 |
| Actual end date | 2024-07-08 |
| Shortage status | Resolved |
| Updated date | 2024-07-09 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 4600 RUE ARMAND-FRAPPIER SAINT-HUBERT, QUEBEC CANADA J3Z 1G5 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2024-07-09 | English | Compare |
| v8 | 2024-07-08 | French | Compare |
| v7 | 2024-07-08 | English | Compare |
| v6 | 2024-07-02 | French | Compare |
| v5 | 2024-07-02 | English | Compare |
| v4 | 2024-06-13 | English | Compare |
| v3 | 2024-06-12 | French | Compare |
| v2 | 2024-06-12 | English | Compare |
| v1 | 2024-06-12 | English | Compare |
Showing 1 to 9 of 9